We are delighted to introduce you to the newest members of our Foundation Board of Directors.

Dr. Ajay Goel, PhD, MS, AGAF. is a professor and Chair of the Department of Molecular Diagnostics and Experimental Therapeutics at City of Hope... Read More

Dr. Peter Langecker, MD, PhD is currently Executive Medical Director, Global Oncology at Clinipace. He brings to the Board over 25 years of hands-on experience in establishing and conducting industry-sponsored oncology and hematology clinical research and development. Read More

Hemanshu Shah is Vice President of Corporate Development & Medical Affairs for Transgene SA, a French biotechnology company. He has more than 30 years of experience in the pharmaceutical/biotechnology industry, including more than 10 years in the oncology therapeutic area. Read More